CHAM
AGIO icon

Clear Harbor Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Clear Harbor Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,325
Closed -$243K – 248
2017
Q2 		$243K Sell
4,325
-305
-7% -$15.6K 0.05% 217
2017
Q1 		$270K Buy
+4,630
New +$222K 0.05% 203

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Clear Harbor Asset Management's AGIO Position: Q3 2017 in Review

Clear Harbor Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2017, closing a stake of 4,325 shares — an estimated $243K sold.

Clear Harbor Asset Management first reported a position in AGIO in Q1 2017 and held it in 2 quarters. The position peaked at $270K in Q1 2017. 171 funds tracked by Wall St. Rank hold AGIO as of Q3 2017.

  • Clear Harbor Asset Management reported no remaining Agios Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Clear Harbor Asset Management sold 4,325 Agios Pharmaceuticals shares in Q3 2017, an estimated $243K.
  • Clear Harbor Asset Management first reported a position in Agios Pharmaceuticals in Q1 2017 and held it in 2 quarters.
  • Clear Harbor Asset Management's Agios Pharmaceuticals position peaked at $270K in Q1 2017.
  • 171 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2017.

Based on Clear Harbor Asset Management's 13F filing for Q3 2017, filed 25 Oct 2017.